4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine

C102H104Cl5N21O6 — CID 158041015

IUPAC4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine
SMILESCOCCN(C)c1nc(-c2ccc(Cl)cc2)c2cnccn12.Cc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-n2cc(CN3CCOCC3)c3ccncc32)cc1.OC1CCN(Cc2cn(-c3ccc(Cl)cc3)c3cnccc23)CC1.OCCNCc1cn(-c2ccc(Cl)cc2)c2cnccc12
InChIInChI=1S/C19H20ClN3O.C18H18ClN3O.C17H18N4O.C16H15ClN4O.C16H17ClN4O.C16H16ClN3O/c20-15-1-3-16(4-2-15)23-13-14(18-5-8-21-11-19(18)23)12-22-9-6-17(24)7-10-22;19-15-1-3-16(4-2-15)22-13-14(12-21-7-9-23-10-8-21)17-5-6-20-11-18(17)22;1-13-2-4-14(5-3-13)16-15-12-18-6-7-21(15)17(19-16)20-8-10-22-11-9-20;17-13-3-1-12(2-4-13)15-14-11-18-5-6-21(14)16(19-15)20-7-9-22-10-8-20;1-20(9-10-22-2)16-19-15(12-3-5-13(17)6-4-12)14-11-18-7-8-21(14)16;17-13-1-3-14(4-2-13)20-11-12(9-19-7-8-21)15-5-6-18-10-16(15)20/h1-5,8,11,13,17,24H,6-7,9-10,12H2;1-6,11,13H,7-10,12H2;2-7,12H,8-11H2,1H3;1-6,11H,7-10H2;3-8,11H,9-10H2,1-2H3;1-6,10-11,19,21H,7-9H2
InChIKeyFIIUMIHAJSZJDN-UHFFFAOYSA-N
MW1897.36 g/mol
LogP18.47
Rot. Bonds20

About 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine

4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine (PubChem CID 158041015) has the molecular formula C102H104Cl5N21O6 and a molecular weight of 1897.36 g/mol. Its IUPAC name is 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine.

Molecular Properties

Compound Name4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine
PubChem CID158041015
Molecular FormulaC102H104Cl5N21O6
Molecular Weight1897.36 g/mol
Exact Mass1893.69
IUPAC Name4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine
SMILESCOCCN(C)c1nc(-c2ccc(Cl)cc2)c2cnccn12.Cc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-n2cc(CN3CCOCC3)c3ccncc32)cc1.OC1CCN(Cc2cn(-c3ccc(Cl)cc3)c3cnccc23)CC1.OCCNCc1cn(-c2ccc(Cl)cc2)c2cnccc12
InChIInChI=1S/C19H20ClN3O.C18H18ClN3O.C17H18N4O.C16H15ClN4O.C16H17ClN4O.C16H16ClN3O/c20-15-1-3-16(4-2-15)23-13-14(18-5-8-21-11-19(18)23)12-22-9-6-17(24)7-10-22;19-15-1-3-16(4-2-15)22-13-14(12-21-7-9-23-10-8-21)17-5-6-20-11-18(17)22;1-13-2-4-14(5-3-13)16-15-12-18-6-7-21(15)17(19-16)20-8-10-22-11-9-20;17-13-3-1-12(2-4-13)15-14-11-18-5-6-21(14)16(19-15)20-7-9-22-10-8-20;1-20(9-10-22-2)16-19-15(12-3-5-13(17)6-4-12)14-11-18-7-8-21(14)16;17-13-1-3-14(4-2-13)20-11-12(9-19-7-8-21)15-5-6-18-10-16(15)20/h1-5,8,11,13,17,24H,6-7,9-10,12H2;1-6,11,13H,7-10,12H2;2-7,12H,8-11H2,1H3;1-6,11H,7-10H2;3-8,11H,9-10H2,1-2H3;1-6,10-11,19,21H,7-9H2
InChIKeyFIIUMIHAJSZJDN-UHFFFAOYSA-N
XLogP18.47
TPSA249.64 Ų
H-Bond Donors3
H-Bond Acceptors27
Rotatable Bonds20
Heavy Atoms134
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001897.36
LogP ≤ 518.47
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1027

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
The IUPAC name of 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine (CID 158041015) is 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine.
What is the SMILES notation for 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
The canonical SMILES for 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine is COCCN(C)c1nc(-c2ccc(Cl)cc2)c2cnccn12.Cc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-c2nc(N3CCOCC3)n3ccncc23)cc1.Clc1ccc(-n2cc(CN3CCOCC3)c3ccncc32)cc1.OC1CCN(Cc2cn(-c3ccc(Cl)cc3)c3cnccc23)CC1.OCCNCc1cn(-c2ccc(Cl)cc2)c2cnccc12.
What is the InChIKey of 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
The InChIKey is FIIUMIHAJSZJDN-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H20ClN3O.C18H18ClN3O.C17H18N4O.C16H15ClN4O.C16H17ClN4O.C16H16ClN3O/c20-15-1-3-16(4-2-15)23-13-14(18-5-8-21-11-19(18)23)12-22-9-6-17(24)7-10-22;19-15-1-3-16(4-2-15)22-13-14(12-21-7-9-23-10-8-21)17-5-6-20-11-18(17)22;1-13-2-4-14(5-3-13)16-15-12-18-6-7-21(15)17(19-16)20-8-10-22-11-9-20;17-13-3-1-12(2-4-13)15-14-11-18-5-6-21(14)16(19-15)20-7-9-22-10-8-20;1-20(9-10-22-2)16-19-15(12-3-5-13(17)6-4-12)14-11-18-7-8-21(14)16;17-13-1-3-14(4-2-13)20-11-12(9-19-7-8-21)15-5-6-18-10-16(15)20/h1-5,8,11,13,17,24H,6-7,9-10,12H2;1-6,11,13H,7-10,12H2;2-7,12H,8-11H2,1H3;1-6,11H,7-10H2;3-8,11H,9-10H2,1-2H3;1-6,10-11,19,21H,7-9H2.
What are the key properties of 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine?
4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine has a molecular weight of 1897.36 g/mol, XLogP of 18.47, 20 rotatable bonds, 3 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[1-(4-chlorophenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine;1-(4-chlorophenyl)-N-(2-methoxyethyl)-N-methylimidazo[1,5-a]pyrazin-3-amine;2-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methylamino]ethanol;4-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]morpholine;1-[[1-(4-chlorophenyl)pyrrolo[2,3-c]pyridin-3-yl]methyl]piperidin-4-ol;4-[1-(4-methylphenyl)imidazo[1,5-a]pyrazin-3-yl]morpholine is sourced from PubChem (CID 158041015), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).